How is India progressing towards developing gene therapy for sickle cell disease

1. India has made significant progress in developing gene therapy for sickle cell disease, with a focus on utilizing CRISPR-Cas9 technology for gene editing. 2. Recent developments include ongoing research and clinical trials to assess the safety and efficacy of gene therapy for sickle cell disease in Indian patients. 3. Key officials and researchers have expressed optimism about the potential of gene therapy to provide a promising treatment option for individuals with sickle cell disease. 4. Collaborations between Indian scientific institutions, biotech companies, and international partners are helping in advancing research and development efforts in this field. 5. However, challenges such as regulatory approval and ensuring accessibility of gene therapy to all sections of the population remain to be addressed for widespread implementation.